We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.21B
AUM Growth
+$1.17B
Cap. Flow
+$1.31B
Cap. Flow %
15.93%
Top 10 Hldgs %
19.59%
Holding
1,801
New
278
Increased
701
Reduced
627
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Financials 9.29%
3 Industrials 9.2%
4 Healthcare 6.57%
5 Communication Services 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
551
Vail Resorts
MTN
$5.24B
$2.25M 0.03%
17,571
+2,893
+20% +$395K
IFF icon
552
International Flavors & Fragrances
IFF
$19.5B
$2.25M 0.03%
31,065
+3,930
+14% +$288K
AZN icon
553
AstraZeneca
AZN
$262B
$2.24M 0.03%
+11,370
New +$2.19M
MET icon
554
MetLife
MET
$60.6B
$2.23M 0.03%
31,592
-425
-1% -$31.8K
GSY icon
555
Invesco Ultra Short Duration ETF
GSY
$3.82B
$2.23M 0.03%
44,545
-3,600
-7% -$181K
USTB icon
556
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.28B
$2.23M 0.03%
44,080
-412
-0.9% -$21K
SPMO icon
557
Invesco S&P 500 Momentum ETF
SPMO
$21B
$2.23M 0.03%
19,878
-10,357
-34% -$1.22M
VIS icon
558
Vanguard Industrials ETF
VIS
$8.22B
$2.22M 0.03%
7,123
+520
+8% +$169K
VMBS icon
559
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$2.22M 0.03%
47,281
+1,273
+3% +$60.1K
BSX icon
560
Boston Scientific
BSX
$66.2B
$2.22M 0.03%
35,335
-4,613
-12% -$369K
CINF icon
561
Cincinnati Financial
CINF
$28.1B
$2.21M 0.03%
14,061
-466
-3% -$75.8K
SPLV icon
562
Invesco S&P 500 Low Volatility ETF
SPLV
$7.19B
$2.21M 0.03%
30,181
-1,479
-5% -$110K
EFG icon
563
iShares MSCI EAFE Growth ETF
EFG
$16.3B
$2.19M 0.03%
19,683
+850
+5% +$100K
VCR icon
564
Vanguard Consumer Discretionary ETF
VCR
$5.83B
$2.19M 0.03%
6,090
+392
+7% +$151K
ESLT icon
565
Elbit Systems
ESLT
$38.5B
$2.18M 0.03%
2,572
+734
+40% +$565K
DY icon
566
Dycom Industries
DY
$12.9B
$2.18M 0.03%
6,441
+2,142
+50% +$805K
RCL icon
567
Royal Caribbean
RCL
$78.5B
$2.18M 0.03%
7,921
+4,290
+118% +$1.28M
HLNE icon
568
Hamilton Lane
HLNE
$3.63B
$2.17M 0.03%
21,877
+4,545
+26% +$558K
RL icon
569
Ralph Lauren
RL
$22.2B
$2.16M 0.03%
6,266
-506
-7% -$180K
NET icon
570
Cloudflare
NET
$93.1B
$2.15M 0.03%
10,422
-828
-7% -$158K
JPIB icon
571
JPMorgan International Bond Opportunities ETF
JPIB
$2.07B
$2.14M 0.03%
44,734
-98
-0.2% -$4.78K
SCHX icon
572
Schwab US Large- Cap ETF
SCHX
$70.8B
$2.14M 0.03%
83,323
-3,532
-4% -$94.7K
FTSL icon
573
First Trust Senior Loan Fund ETF
FTSL
$2.31B
$2.14M 0.03%
47,674
+1,938
+4% +$87.8K
EFV icon
574
iShares MSCI EAFE Value ETF
EFV
$27.6B
$2.12M 0.03%
28,487
+1,778
+7% +$134K
VTOL icon
575
Bristow Group
VTOL
$1.36B
$2.11M 0.03%
45,100
-3,400
-7% -$149K

Similar funds

Oppenheimer & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Oppenheimer & Co held 1,801 positions worth $8.21B, up 17% from $7.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co deployed $1.31B of net new capital in Q1 2026, opening 278 new positions and adding to 701 existing holdings. Its largest new stake was Apple: 1,107,179 shares worth $281M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $11.2M trimmed.

  • Oppenheimer & Co's largest Q1 2026 buy was Apple: 1,107,179 shares worth $281M.
  • Oppenheimer & Co added most to Microsoft in Q1 2026, an estimated $24M increase.
  • Oppenheimer & Co's biggest Q1 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $11.2M.
  • Oppenheimer & Co fully exited Telefonica in Q1 2026, selling an estimated $6.36M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $8.21B portfolio in Q1 2026.
  • Oppenheimer & Co opened 278 new positions and closed 118 in Q1 2026.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $8.21B.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.